The Pharmacist’s Role in Opioid Analgesia: Supporting the Pain Patient While Preventing Overdose, Misuse, and Diversion

Mara N. Villanueva, PharmD
Published Online: Wednesday, July 16, 2014
Follow Pharmacy_Times:
This activity is supported by educational grants from Purdue Pharma LP, Teva Pharmaceuticals, and Zogenix, Inc.

The Pharmacist’s Role in Opioid Analgesia: Supporting the Pain Patient While Preventing Overdose, Misuse, and Diversion

Faculty
Mara N. Villanueva, PharmD
Clinical Pharmacy Specialist
Pharmacy Medication Management
and Analytics
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Educational Objectives
At the conclusion of this educational activity, participants should be able to:
  • Examine the risk factors associated with the highest rates of opioid overdose.
  • Identify the characteristics and red flags of patients who intend to use or distribute opioids for non-medical reasons.
  • Review the information that is important to communicate to patients regarding appropriate opioid medication use, storage, and disposal.
  • Describe how pharmacists can support the current Risk Evaluation and Mitigation Strategy programs for extended-release, long-acting, and transmucosal immediate-release fentanyl opioid products, and identify the tools available to prevent opioid misuse, diversion, and abuse.
Intended Audience
Pharmacists

Release date: July 8, 2014
Expiration date: July 8, 2016
Estimated time to complete activity: 1.5 hours
Fee: Free

Click here to view this activity.
Click here to view this activity. - See more at: http://www.pharmacytimes.com/publications/issue/2014/June2014/Optimizing-the-Management-of-Asthma-The-Critical-Role-of-the-Pharmacist#sthash.7ZeRdjp8.dpuf
Click here to view this activity.

Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-14-062-H03-P. The activity is available for CE credit through July 8, 2016.

Related Articles
Responding to a request from state officials to provide greater access to naloxone, CVS Health, Walgreens, and other chain pharmacies will stock and dispense the opioid overdose antidote in stores across Maryland, as well as train their pharmacists on administering the lifesaving medication.
With Pennsylvania pharmacies now authorized to fill third-party naloxone prescriptions and California pharmacies set to dispense naloxone without any prescription at all, more and more pharmacists are providing a critical public pathway to the opioid overdose antidote.
Mylan Inc. announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's Celebrex® Capsules, which is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults.
When a would-be robber entered a pharmacy in Wyoming with what looked like a real gun, a pharmacist behind the counter reached for his firearm and injured the suspect by shooting him, according to the Wyoming Tribune Eagle.
Latest Issues
$auto_registration$